/hormone-supplement-overview
Estrovera overview: a dietary supplement marketed to support vasomotor symptoms. Review of ERr 731, its studied uses, and how it fits into menopause wellness options.

Not medical advice. Speak with a healthcare professional before using any medication.

Efficacy information based on publicly available clinical literature and peer-reviewed research.
Estrovera is a non-hormonal dietary supplement centered on a single plant-derived extract that is marketed to support vasomotor symptom comfort, particularly hot flash management.
Estrovera is a branded product made by Metagenics. Its key ingredient is ERr 731, a standardized extract of Rheum rhaponticum (Siberian rhubarb). This is not estrogen and does not function as hormone replacement. Per a study indexed on PubMed (PMID 34167315), ERr 731 appears to act on specific serotonin receptor pathways involved in thermoregulation, which may help support comfort from hot flashes without altering measurable hormone levels—individual responses vary.
The product contains only a small number of components: the ERr 731 extract at a fixed daily dose (usually 4 mg) plus inactive tablet ingredients. According to manufacturer labeling for Estrovera, this consistency in formulation is part of why it has been more formally studied than many other botanical menopause supplement products.
Estrovera is positioned as a non-prescription option for individuals who prefer not to use hormones or who, following discussion with a prescriber, have determined that hormonal options are not suitable. As a non-hormonal dietary supplement under DSHEA, it works through different mechanisms than prescription hormone therapy—these are different product categories with different evidence bases. Per Natural Medicines database, ERr 731 has been evaluated in multiple controlled trials, which many clinicians view as distinguishing it from less-studied botanical products. Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.

At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsAccording to manufacturer labeling for Estrovera, this product may help support comfort from hot flashes for many women, with effects described as moderate and most noticeable for vasomotor symptoms rather than the full range of menopause-related concerns.
Per a study indexed on PubMed (PMID 27547165), Estrovera's active ingredient (ERr 731, a rhubarb root extract) has a small but fairly consistent evidence base. In the trials reviewed, women taking it reported:
Per a study indexed on PubMed (PMID 23091400), reported benefits typically became apparent by week 4–6. In clinical observations, individuals who reported support often described it as "taking the edge off" rather than a dramatic shift in overall hormonal status.
In summary, Estrovera is marketed as one of the more studied non-prescription botanical options for vasomotor symptom support. As a non-hormonal dietary supplement under DSHEA, it works through different mechanisms than prescription hormone therapy—these are different product categories with different evidence bases. Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
Per a study indexed on PubMed (PMID 27547165), Estrovera's rhapontic rhubarb extract (ERr 731) was associated with reported support for frequency and intensity of hot flashes in a controlled study population. According to manufacturer labeling for Estrovera, this product may help support vasomotor symptom comfort as a non-hormonal dietary supplement option; individual responses vary.
According to manufacturer labeling for Estrovera, by may helping support nighttime vasomotor symptoms and thermoregulation, Estrovera is marketed to support more consistent sleep during menopause. Per peer-reviewed literature cited on this page, improvements in sleep quality reported by participants tended to correspond with vasomotor support; individual responses vary.
Per a study indexed on PubMed (PMID 30786797), some participants reported milder mood-related concerns and reduced irritability. According to manufacturer labeling for Estrovera, these reported outcomes are thought to correspond with vasomotor support rather than direct hormonal effects; individual responses vary.
Per the NIH Office of Dietary Supplements, dietary supplements such as Estrovera are regulated under DSHEA and are not hormones. ERr 731 is marketed to act on serotonin receptor pathways selectively—as a non-hormonal dietary supplement, it works through different mechanisms than prescription hormone therapy. These are different product categories with different evidence bases; a prescriber should determine whether Estrovera or another option is appropriate for an individual patient.
You don’t have to figure it out alone. Our pharmacists are available to answer questions and help you make an informed choice, based on your needs.

According to manufacturer labeling for Estrovera, this product is marketed to support comfort from moderate vasomotor symptoms such as hot flashes and night sweats as a non-hormonal, supplement-based option with more clinical study data than most OTC botanical products in this category.
Per a study indexed on PubMed (PMID 23091400), the active ingredient in Estrovera (ERr 731, a Siberian rhubarb extract) was associated with reported support for vasomotor symptoms for many women within 4–8 weeks. Per peer-reviewed literature cited on this page, reported responses include meaningful support for vasomotor concerns, with individual variation. It may be most relevant for individuals who:
In reported use, individuals who respond often describe a steady change in frequency and intensity of hot flashes rather than complete elimination. As a non-hormonal dietary supplement under DSHEA, Estrovera works through different mechanisms than prescription hormone therapy—these are different product categories with different evidence bases.
If your symptoms are mild-to-moderate and you want a non-hormonal supplement option with clinical data, Estrovera may be worth discussing with a healthcare provider. Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Learn about Estrovera: dosage, side effects, important considerations, and cost for informed conversations with your healthcare provider.
Learn whether Estrovera requires a prescription, how it works, and safe options for managing menopausal symptoms with this supplement.